Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719095 · ClinicalTrials.gov registry record · Phase 2
Effective Treatment for Prescription Opioid Abuse
A Phase 2 study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT00719095 is a Phase 2 study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 105 participants.
The verdict
NCT00719095, a Phase 2 study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
There has been an alarming increase in abuse of prescription opioids in recent years. This project aims to develop an effective outpatient treatment for prescription opioid (PO) abuse that combines an intensive behavioral therapy with a pharmacotherapy regimen of buprenorphine detoxification and naltrexone maintenance.
Interventions
- BEHAVIORAL Behavioral therapy
- DRUG buprenorphine taper followed by naltrexone maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00719095
The ClinicalTrials.gov registry entry for NCT00719095 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral therapy is the first listed.
NCT00719095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00719095 about?
NCT00719095 is a clinical study titled "Effective Treatment for Prescription Opioid Abuse". There has been an alarming increase in abuse of prescription opioids in recent years. This project aims to develop an effective outpatient treatment for prescription opioid (PO) abuse that combines an intensive behavioral therapy with a pharmacotherapy regimen of buprenorphine detoxification and nal...
What is the current status of trial NCT00719095?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2006-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00719095?
The interventions under investigation include: Behavioral therapy (BEHAVIORAL), buprenorphine taper followed by naltrexone maintenance (DRUG).
Who is sponsoring clinical trial NCT00719095?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.